Opendata, web and dolomites

MOBIUS SIGNED

MØBIUS: Transforming medication management for improved patient safety

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MOBIUS project word cloud

Explore the words cloud of the MOBIUS project. It provides you a very rough idea of what is the project "MOBIUS" about.

dispensation    integration    errors    22    medicine    seal    business    logistics    implementable    eliminating    submission    healthcare    saves    iceland    solutions    q1    stock    oslash    medication    loops    strategy    sufficient    entire    data    companies    brings    services    validating    winning    exchange    excellence    search    packaging    class    integrates    time    improvement    designed    first    unused    pharmacies    automation    platform    removes    generate    2021    intends    accountability    flow    expenditures    commercialization    inefficiencies    oecd    waste    safety    ensures    security    linking    wasting    commercial    entry    roi    company    facilities    dramatically    plan    bius    prescription    pharmaceuticals    13    dispensing    transform    award    finalizing    solution    20    manual    fraction    automated    electronic    proposition    enhanced    mission    inst    jobs    prescriptions    sme    robots    thula    market    traceability    medicines    drug    realistic    improves    reduces    integrating    patient    drugs    hospital       investment    cumulative    health    95    software    countries   

Project "MOBIUS" data sheet

The following table provides information about the project.

Coordinator
THULA-NORRAENT HUGVIT EHF 

Organization address
address: GLERARGOTU 28
city: AKUREYRI
postcode: 600
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Iceland [IS]
 Project website http://thula.is
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THULA-NORRAENT HUGVIT EHF IS (AKUREYRI) coordinator 50˙000.00

Map

 Project objective

Thula is an award-winning IT company based in Iceland with the mission of providing first class e-health solutions for medication management, logistics and electronic exchange of healthcare information. Thula has developed MØBIUS, a unique software solution that can manage the entire medication flow of hospital pharmacies, long-term healthcare facilities or companies providing healthcare services and logistics. Pharmaceuticals account for 20% of overall healthcare expenditures in OECD countries but a significant fraction of this investment could be reduced by eliminating inefficiencies in drug management (e.g., errors in prescription and dispensation; waste of unused medicines). MØBIUS is an integration platform designed to transform medicine management through enhanced automation. By linking different systems in the medication- and logistics loops, MØBIUS dramatically reduces inefficiencies in stock management and increases patient safety and security. MØBIUS integrates Electronic Prescriptions, automated dispensing robots and distribution systems. It also ensures availability of sufficient drugs for the patient, processes drug dispensing effectively, removes time wasting, saves resources, allows easy access to medicine, brings on more security on the data compared to manual-based systems, and improves accountability and traceability. The objectives of the SME Inst project include finalizing and validating the development of MØBIUS by integrating and packaging advanced features; search of commercial partners in target EU countries; in-depth assessment of entry strategy into the EU healthcare market; and a realistic and implementable business plan. We expect MØBIUS will generate about 40 new jobs and a cumulative ROI of €5.95 in the first 4 years after commercialization in Q1 2021. This submission, an improvement of a previous call in which we achieved a Seal of Excellence (13.22), intends to further demonstrate MØBIUS’ approach and our company’s value proposition.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOBIUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOBIUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

MIGRATECH 4.0 (2019)

The revolution in micro-granulation technology for eco-friendly, production efficient, superior ceramic tiles

Read More